Abstract
Selective serotonin reuptake inhibitors (SSRIs) are widely prescribed after stroke. We aimed to investigate whether potential antiplatelet or vasospastic effects have important clinical implications.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Stroke |
Vol/bind | 44 |
Udgave nummer | 2 |
Sider (fra-til) | 420-6 |
Antal sider | 7 |
ISSN | 0039-2499 |
DOI | |
Status | Udgivet - 2013 |
Udgivet eksternt | Ja |